Prokidney (PROK) Retained Earnings (2021 - 2026)
Prokidney's (PROK) quarterly Retained Earnings came in at -$1.3 billion in Q2 2026, down 6.82% year-over-year from -$1.4 billion in Q2 2025, and down 2.2% quarter-over-quarter from -$1.3 billion in Q1 2026.
Analysis
Prokidney (PROK) Retained Earnings (2021 - 2026) Analysis & Trends
Prokidney (PROK) has reported Retained Earnings for 6 consecutive years, with -$1.3 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Retained Earnings fell 6.82% year-over-year to -$1.3 billion in Q2 2026; TTM through Jun 2026 was -$1.3 billion, a 6.82% decrease from a year earlier, with the FY2025 full-year figure at -$1.3 billion, down 5.74% from the prior year.
- Retained Earnings was -$1.3 billion for Q2 2026 at Prokidney, down from -$1.3 billion in the prior quarter.
- Over five years, Retained Earnings peaked at -$12.4 million in Q1 2022 and troughed at -$1.6 billion in Q1 2023.
- A 5-year average of -$1.1 billion and a median of -$1.2 billion in 2024 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings tumbled 61667.36% in 2022 and rose 29.21% in 2024, its largest moves.
- Over 5 years, Retained Earnings stood at -$1.1 billion in 2022, then fell by 3.22% to -$1.1 billion in 2023, then fell by 5.37% to -$1.2 billion in 2024, then retreated by 5.74% to -$1.3 billion in 2025, then fell by 3.82% to -$1.3 billion in 2026.
- The last three Retained Earnings figures came in at -$1.3 billion (Q2 2026), -$1.3 billion (Q1 2026), and -$1.3 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 1.23 Bn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | -2.16 Bn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 3.62 Bn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 1.23 Bn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 1.84 Bn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | 2.93 Bn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 2.37 Bn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | -4.55 Bn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | -380.40 Mn |
| 10 | Prokidney | 346.07 Mn | 346.07 Mn | - | -1.32 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.32 Bn |
| Mar 31, 2026 | -1.29 Bn |
| Dec 31, 2025 | -1.27 Bn |
| Sep 30, 2025 | -1.25 Bn |
| Jun 30, 2025 | -1.23 Bn |
| Mar 31, 2025 | -1.22 Bn |
| Dec 31, 2024 | -1.20 Bn |
| Sep 30, 2024 | -1.18 Bn |
| Jun 30, 2024 | -1.16 Bn |
| Mar 31, 2024 | -1.15 Bn |
| Dec 31, 2023 | -1.14 Bn |
| Sep 30, 2023 | -1.13 Bn |
| Jun 30, 2023 | -1.35 Bn |
| Mar 31, 2023 | -1.62 Bn |
| Dec 31, 2022 | -1.10 Bn |
| Sep 30, 2022 | -1.10 Bn |
| Jun 30, 2022 | -15.00 Mn |
| Mar 31, 2022 | -12.36 Mn |
| Dec 31, 2021 | -161.51 Mn |
| Sep 30, 2021 | -6.32 Mn |